Founded in 1997, it is a comprehensive enterprise mainly engaged in the production of Chinese patent medicines and biochemicals, and its compound bear bile eye drops have significant effects on the treatment of bacterial ocular conjunctivitis and epidemic keratoconjunctivitis
Changchun Puhua Pharmaceutical Co., Ltd. was founded in November 1997, mainly engaged in the research and development, production and sales of Chinese patent medicines and chemical drugs, and is a high-tech enterprise and GMP certified enterprise in Jilin Province.The company is located in the beautiful northern spring city of Changchun, located in the high-tech industrial technology development zone No. 1105 Torch Road, covers an area of 27,000 square meters, GMP workshop and construction area of about 12,000 square meters.
Changchun Puhua Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating R&D, production and sales, mainly engaged in the production of Chinese patent medicines and biochemical drugs. The company has advanced production equipment, scientific management system, strong R & D force, reliable product quality and elite sales team. The company's products involve many medical fields such as otolaryngology, dermatology, musculoskeletal system diseases, cardiovascular and cerebrovascular diseases, respiratory diseases, etc., covering eye drops, ointments, small-volume injections, drops, tablets, capsules, granules, APIs and other dosage forms. The company has formed a product pattern of "featuring Chinese patent medicine, ophthalmic drugs and dermatological drugs, supplemented by drugs in musculoskeletal system and other fields", the main products include compound bear bile eye drops, benzyl lysine eye drops, myopia eye drops, paeonol ointment, capsaicin cream, Yixin ketone drop pills, etc., with distinctive product characteristics and unique competitive advantages in specific therapeutic areas and market segments. In terms of product reserves, the company has a number of high-quality products with industrialization conditions and great market potential, such as Danxiong bone-setting ointment, a characteristic Chinese patent medicine preparation for acute and subacute soft tissue injury, which is the company's exclusive variety, and mesteine hydrochloride tablets, ginseng huang ointment and other products have good market prospects.
Among the company's main products, compound bear bile eye drops are new drugs for the treatment of bacterial ocular conjunctivitis and epidemic keratoconjunctivitis; Capsaicin cream is a new type of long-acting analgesic with a unique mechanism, which directly acts on nerve endings, has no systemic side effects, is suitable for long-term use, and is included in the national medical insurance catalog; Paeonol ointment is a traditional Chinese medicine preparation for various skin diseases such as eczema, dermatitis, skin itching, mosquito bed bites, redness and swelling, without hormones, no drug dependence and other side effects; Yixin Keto Drop Pill is prepared by a new process, which has the characteristics of fast efficacy, high bioavailability, safe use and low toxicity and side effects. Among the company's other products, Danxiong bone-setting ointment has the effect of invigorating blood and dissipating blood stasis, reducing swelling and relieving pain, and is a characteristic Chinese patent medicine preparation for acute and subacute soft tissue injury, which is the company's exclusive variety; Meselein Mesteine Hydrochloride Tablets is an over-the-counter drug used to reduce phlegm, and its indications are similar to those of the best-selling drug Musutan, and the company is the only manufacturer with its API and tablet drug approval numbers at the same time
The company has strong new drug R&D strength and has a new drug R&D team dominated by R&D personnel. Over the years, a large amount of R&D funds have been invested in the fields of genetic engineering drugs and modern Chinese medicine, and a number of high-level new drugs with independent intellectual property rights have entered the new drug application procedure, which has laid a firm foundation for the company's development.
The company takes "serving the society, taking responsibility, paying attention to employees, and growing together" as its business philosophy, and "responsibility, loyalty, execution, dedication, honor" as its enterprise spirit, and its business level has been continuously improved, and its marketing network has spread all over the country, and its high-quality products have been well received by patients.
Changchun Puhua Pharmaceutical Co., Ltd. will, as always, adhere to the company's business philosophy, and provide high-quality products and services for the health of the public with a rigorous working attitude and first-class work level.
